Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
367M
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
68M
-
Shares change
-
+4.07M
-
Total reported value, excl. options
-
$3.28B
-
Value change
-
+$195M
-
Put/Call ratio
-
0.35
-
Number of buys
-
90
-
Number of sells
-
-67
-
Price
-
$48.22
Significant Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q1 2023
197 filings reported holding LEGN - Legend Biotech Corp - COMMON STOCK as of Q1 2023.
Legend Biotech Corp - COMMON STOCK (LEGN) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68M shares
of 367M outstanding shares and own 18.52% of the company stock.
Largest 10 shareholders include FMR LLC (16.4M shares), HHLR ADVISORS, LTD. (5.13M shares), BlackRock Inc. (4.13M shares), RA CAPITAL MANAGEMENT, L.P. (2.44M shares), Capital World Investors (2.39M shares), FEDERATED HERMES, INC. (2.34M shares), Polar Capital Holdings Plc (1.98M shares), Capital International Investors (1.95M shares), JANUS HENDERSON GROUP PLC (1.94M shares), and WELLINGTON MANAGEMENT GROUP LLP (1.76M shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.